Zhejiang Jiuzhou Pharmaceutical Co., Ltd
SHH: 603456.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi Jiang Mei
- Employees
- 5,001
- Headquarters
- Taizhou, China
- IPO year
- 2014
- Market cap
- CN¥12.2B
- Website
- https://www.jiuzhoupharma.com
Loading 603456…
Loading profile data…Frequently asked questions about 603456
What does Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) do?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and...
Where does 603456.SS trade?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) trades on the Shanghai Stock Exchange.
What sector is 603456.SS in?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Jiuzhou Pharmaceutical Co., Ltd?
Yi Jiang Mei is the chief executive officer of Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS).
Where is Zhejiang Jiuzhou Pharmaceutical Co., Ltd headquartered?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is headquartered in China.
Does 603456.SS pay a dividend?
Yes — Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) paid a trailing twelve-month dividend of CNY 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603456.SS go public?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) completed its initial public offering in 2014.